COMMUNIQUÉS West-GlobeNewswire

Alarming Study Reveals Safety Limits are Exceeded for Mercury Exposure from Dental Amalgams in Pregnant Women in the U.S.
14/02/2024
CHAMPIONSGATE, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) urgently highlights a concerning study, titled " Estimated mercury vapor exposure from amalgams [...]
Unity Care Awarded Grant Under "Outdoors for All" Initiative by California Natural Resources Agency and Governor Newsom
14/02/2024
SAN JOSE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Unity Care, a nonprofit organization that serves transition-age foster youth, has been selected to receive a grant under the “Outdoors for All” program, an initiative [...]
Statement of Renovaro Inc
14/02/2024
LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in response to Hindenburg's recent opinion piece: We felt compelled to comment on the shorter Hindenburg’s opinion [...]
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global
14/02/2024
Proposed Combination to Focus on Securing Our Nation’s Supply to Critical Materials and Resources MINNEAPOLIS, MN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today [...]
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
14/02/2024
Global License of Industry-Leading Elite Herbicide Tolerant Camelina Accelerates Biofuel Feedstock Production WOBURN, Mass. and LONGMONT, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN [...]
Nacuity Pharmaceuticals Announces Expansion of its Business Advisory Board with Appointment of Rare Disease Advocate Daniel Feller
14/02/2024
FORT WORTH, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other ocular diseases caused [...]
SweetWater 420 Fest Announces 2024 Lineup With Headliners Beck and Slightly Stoopid
14/02/2024
Two-Day Festival Will Feature Performances from 25 Musicians, April 20 & 21, at Atlanta’s Historic Pullman Yards ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “ [...]
Bicycle Health’s Second Opioid Use Disorder Index Reveals Persistent Gaps in Treatment
14/02/2024
New population-level data shows that people with opioid use disorder (OUD) struggle to access treatment, even following the elimination of the X-waiver. While 78% of people looking for virtual OUD treatment have [...]
AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
14/02/2024
Phase 1b portion of the study expected to be completed within six months OCALA, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the first subject [...]
ZKR Orthopedics Receives IDE Approval for Clinical Trial
14/02/2024
SAN FRANCISCO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc., a clinical stage medical device company, announced that it has received Investigational Device Exemption (IDE) approval from the United States Food [...]
SFWJ DBA MedCana Announces a Major Multiyear Contract between Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana and Danziger Colombia
14/02/2024
AUSTIN, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- – via IBN – SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure [...]
Safety Shot Brand Ambassador & Multiplatform Entertainer Matthew Espinosa to Share His Enthusiasm for the Wellness Beverage with 16 Million Followers
14/02/2024
JUPITER, FL, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced that Matthew Espinosa joins Safety Shot as a brand ambassador to share his love and enthusiasm for the first patented [...]
Ashvattha Therapeutics to Participate in Upcoming Investor Conferences
14/02/2024
REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively [...]
Kineta to Present at Upcoming Investor Conferences
14/02/2024
SEATTLE, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, [...]
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
14/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that it will [...]
Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones
14/02/2024
Company developing potential breakthrough technology for the nervous system Initially targeting multi-billion-dollar pancreatic cancer market On track to commence first study ever to evaluate radiofrequency (RF) [...]
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
14/02/2024
NORSE EIGHT underway with first subject dosed and additional clinical sites beginning enrollment Continue to expect planned resubmission of the ONS-5010 Biologics License Application (BLA) by the end of CY2024 [...]
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
14/02/2024
The Company will Host a Conference Call and Webcast on February 29, 2024, at 8:30 AM ET CORAL GABLES, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial- [...]
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
14/02/2024
Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and [...]

Pages